Michael B MacIsaac, Bradley Whitton, Adrian Hubble, Shelley Cogger, Matthew Penn, Anthony Weeks, Kasey Elmore, David Pemberton, Jenine Anderson, Rebecca Howard, Una McKeever, Timothy Papaluca, Margaret E Hellard, Mark Stoove, David Wilson, Alisa Pedrana, Joseph Doyle, Nico Clark, Jacinta Holmes, Alexander J Thompson
OBJECTIVE: To evaluate the feasibility of testing and treating people who inject drugs at a supervised injecting facility for hepatitis C virus (HCV) infection. DESIGN: Retrospective cohort study. SETTING, PARTICIPANTS: People who inject drugs who attended the Melbourne supervised injecting facility, 30 June 2018 - 30 June 2020. MAIN OUTCOME MEASURES: Proportion of people tested for hepatitis C; proportions of people positive for anti-HCV antibody and HCV RNA, and of eligible people prescribed direct-acting antiviral (DAA) treatment; sustained virological response twelve weeks or more after treatment completion...
March 14, 2023: Medical Journal of Australia